Gordana Zamolo

Gordana Zamolo

Auto-generated profile, based on publicly available information

Gordana Zamolo

Department of Pathology, Faculty of Medicine, University of Rijeka, Rijeka, Croatia

Research Focus & Metrics

Academic Career Length

31Years (1996-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 June 2017 in Scientific Reports
Verified
Journal Article
Open access
PDF file
AMAles Maver
Ales Maver
PLPolona Lavtar
Polona Lavtar
SRSmiljana Ristić
Smiljana Ristić
SSSanja Stopinšek
Sanja Stopinšek
SSSaša Simčič
Saša Simčič
BPBorut Peterlin
Borut Peterlin
The genetic etiology and the contribution of rare genetic variation in multiple sclerosis (MS) has not yet been elucidated. Although familial forms of MS have been described, no convincing rare and penetrant variants have been reported to date. We aimed to characterize the contribution of rare genetic variation in familial and sporadic MS and have identified a family with two sibs affected by concomitant MS and malignant melanoma (MM). We performed whole exome sequencing in this primary family and 38 multiplex MS families and 44 sporadic MS cases and performed transcriptional and immunologic assessment of the identified variants. We identified a potentially causative homozygous missense variant in NLRP1 gene (Gly587Ser) in the primary family. Further possibly pathogenic NLRP1 variants were identified in the expanded cohort of patients. Stimulation of peripheral blood mononuclear cells from MS patients with putatively pathogenic NLRP1 variants showed an increase in IL-1B gene expression and active cytokine IL-1β production, as well as global activation of NLRP1-driven immunologic pathways. We report a novel familial association of MS and MM, and propose a possible underlying genetic basis in NLRP1 gene. Furthermore, we provide initial evidence of the broader implications of NLRP1-related pathway dysfunction in MS.

19 October 2004 in British Journal of Dermatology
Verified
Journal Article
Closed access
PDF file
MKM. Kastelan
M. Kastelan
LPLarisa Prpić-Massari
Larisa Prpić-Massari
FGF. Gruber
F. Gruber
GZG. Zamolo
G. Zamolo
GŽGordana Žauhar
Gordana Žauhar
DRD. Rukavina
D. Rukavina

24 May 2002 in Archives of Medical Research
Verified
Journal Article
Closed access
NBNada Brncic
Nada Brncic
IVIvica Viskovic
Ivica Viskovic
ASAntun Sasso
Antun Sasso
IKIvan Kraus
Ivan Kraus
GZGordana Zamolo
Gordana Zamolo

1 January 2004 in Tumori Journal
Verified
Journal Article
Closed access
PDF file
TBTanja Batinac
Tanja Batinac
GZGordana Zamolo
Gordana Zamolo
NJNives Jonjić
Nives Jonjić
FGFranjo Gruber
Franjo Gruber
MPMladen Petrovečki
Mladen Petrovečki
Aims and background: The p53 protein is essential for the regulation of cell proliferation and its aberrant accumulation is usually seen in malignant tumors but also occurs in squamous epithelium of inflammatory skin diseases characterized by hyperproliferation. The aim of this study is to elucidate the role of the p53 tumor suppressor protein in the pathogenesis of different hyperproliferative, non-malignant and malignant skin diseases, and to determine the association between p53 overexpression and cell proliferation. We also investigated the influence of aging on p53 and Ki-67 protein expression. Methods: One hundred and fifty skin specimens divided into 30 samples each of normal skin (NS), psoriatic skin (PS), keratoacanthomas (KA), basal cell carcinomas (BCC), and squamous cell carcinomas (SCC) were examined immunohistochemically to assess p53 and Ki-67 protein expression. Results: p53 immunostaining of NS, PS, KA, BCC and SCC was detected in 39.0%, 46.7%, 66.7%, 80% and 86.7% of cases, respectively. Median values and ranges of p53 protein expression were as follows: 0.0% (range, 0.0–1.8%) in NS, 0.0% (range, 0.0–6.5%) in PS, 9.2% (range, 0.0–24.0%) in KA, 19.3% (range, 0.0–48.1%) in BCC and 30.1% (range, 0.0–68.1%) in SCC. p53- and Ki-67-positive cells were present in basal (NS) and suprabasal layers (PS), and not only in cancer nests of KA, BCC and SCC but also in dysplastic and even morphologically normal epidermis adjoining cancers. The positivity of p53 and Ki-67 proteins differed significantly among the groups, with no differences in p53 expression between NS and PS and in Ki-67 expression between PS and KA. Within all groups there was a significant correlation between p53 and Ki-67 expression. Lesion location and patient age, with the exception of location in PS and age in BCC, were significantly related to p53 and Ki-67 expression in all groups. Conclusions: Our findings suggest that p53 overexpression occurs mainly in neoplastic skin lesions, although it may also occur in squamous epithelium of inflammatory skin diseases such as PS, as well as in normal skin epithelium. It is associated with cell proliferation in normal as well as altered epithelium. p53 protein overexpression is an age-related process and significantly associated with sun exposure, especially in NS and PS but also in KA and SCC. Our findings suggest that Ki-67 rate and p53 protein expression reflect the degree of malignancy in the examined cutaneous neoplasms.

1 July 2007 in Journal of Dermatological Science
Verified
Journal Article
Closed access
LPLarisa Prpić-Massari
Larisa Prpić-Massari
MKMarija Kaštelan
Marija Kaštelan
GLGordana Laškarin
Gordana Laškarin
GZGordana Zamolo
Gordana Zamolo
DMDražen Massari
Dražen Massari
DRDaniel Rukavina
Daniel Rukavina

1 August 2006 in Pathology - Research and Practice
Verified
Journal Article
Closed access
TBTanja Batinac
Tanja Batinac
GZGordana Zamolo
Gordana Zamolo
MCMiran Coklo
Miran Coklo
IHIta Hadžisejdić
Ita Hadžisejdić
CSChristophe Stemberger
Christophe Stemberger
GŽGordana Žauhar
Gordana Žauhar